Patent ID: 11865207
Assignee: FERRING B.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 21:
22. The method of claim 21, wherein:
the hydroxypropylcellulose is present in the pharmaceutical composition in an amount of about 4% w/w;
the diltiazem hydrochloride is present in the pharmaceutical composition in an amount of about 2% w/w;
the lidocaine hydrochloride is present in the pharmaceutical composition in an amount of about 2% w/w;
the propylene glycol is present in the pharmaceutical composition in an amount of about 32% w/w;
the polyethylene glycol is present in the pharmaceutical composition in an amount of about 16% w/w;
the diethyleneglycol monoethyl ether is present in the pharmaceutical composition in an amount of about 23% w/w; and
the one or more caprylocaproyl macrogol-8 glycerides are present in the pharmaceutical composition in an amount of about 16% w/w.